Harm Reduction [A] · edited

What is harm reduction: principles, evidence, and limits

Interface language

This is the community's introductory material about the approach called harm reduction. We will look at what it is, what its principles are, what research shows, and where the approach has its limits.

What it is

Harm reduction is a set of practical measures and a philosophy aimed at reducing the risks and negative consequences associated with psychoactive substance use and other risky behavior. The key idea: the goal is a person's health and safety, not punishment and not a mandatory condition of complete abstinence. The approach does not deny the risks and does not encourage use: it proceeds from the fact that some people continue to use, and therefore helps reduce harm right now.

Where it is applied

Harm reduction strategies are used in the field of substance use, sexual health, and mental health. Typical examples: programs providing sterile needles and syringes (they reduce the risks of HIV transmission among people who inject), condom distribution, and provision of naloxone — a medicine that reverses opioid overdose.

Principles of the approach

In a review by Alison Ritter and Jacqui Cameron (Drug and Alcohol Review, 2006), the key features of harm reduction are formulated as follows:

— the goal is to reduce harm, without making complete abstinence from use a precondition for help;
— recognition that substances are part of society and will not disappear completely;
— a public health framework, not prohibitions;
— priority on immediate and achievable goals;
— pragmatism and humanism: accepting a person as they are, without shame and unattainable ideals.

What research shows

1. Sterile needles and syringes. An observational comparison of 103 cities from 24 countries, cited in a WHO review, showed: in cities with such programs, HIV prevalence among people who inject decreased on average by about 18.6% per year, while in cities without programs it increased by about 8.1% per year. This comparison does not prove that the programs alone caused the entire difference. Reviews do not find convincing data that they provoke initiation of use or increase injection frequency. WHO emphasizes: syringes alone are insufficient — they work in combination with education, access to treatment, and primary care. For hepatitis C, the data are more cautious: the effect depends on coverage and combination with treatment.

2. Naloxone. In its 2014 guidelines (“Community management of opioid overdose”), WHO strongly recommends providing naloxone and training to people who may witness an opioid overdose, including family and friends. In descriptions of naloxone distribution programs with training, mortality in overdoses witnessed by participants was about 1%; the historical estimate without access to naloxone was 2–4%. This is an indirect comparison, not a controlled trial. An observational study in 19 Massachusetts communities (Walley et al., BMJ, 2013) also linked programs with lower mortality: in the group with lower coverage, the adjusted rate ratio was 0.73 (95% confidence interval 0.57–0.91). Important: naloxone acts only on opioids and does not cancel the need to call emergency services.

3. Opioid agonist therapy (methadone, buprenorphine). WHO, UNODC, and UNAIDS recommend it as part of comprehensive prevention: the therapy reduces injection frequency, risk of overdose, and transmission of HIV and hepatitis. This is prescription treatment under medical supervision, not a self-administered measure.

Limits of the approach

Harm reduction is not a panacea and not a replacement for addiction treatment, psychotherapy, or psychiatric care. A significant part of the evidence comes from observational studies, not randomized trials (they are difficult to conduct for ethical reasons), so the figures given should be read as estimates, not guarantees. If you or a loved one has health problems due to substance use, this is a reason to consult a relevant specialist.

What can be done right now

— If there is a risk of opioid overdose — find out whether naloxone and training in its use are available in your country: the rules and forms of access differ from country to country.
— If there are signs of an acute life-threatening emergency, immediately call local emergency services (in many countries a single number works, for example 112), do not leave the person alone, and follow the dispatcher's instructions.
— Primary sources for independent verification are listed below.

About the source

The starting point for the material is the article “Harm Reduction Philosophy” (Mindheal, author — Alex Gorovoy, published February 21, 2023). We are temporarily not including the link to it: when checking the page, a foreign script was found.

This is an independent text, not a translation and not a copy of the article: the points are retold in our own words, and facts and figures have been verified against primary sources:

— Alison Ritter, Jacqui Cameron. A review of the efficacy and effectiveness of harm reduction strategies for alcohol, tobacco and illicit drugs. Drug and Alcohol Review, 2006, 25(6): 611–624. https://doi.org/10.1080/09595230600944529
— WHO. Community management of opioid overdose, 2014. https://www.who.int/publications/i/item/9789241548816
— Walley A. Y. et al. Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis. BMJ, 2013, 346:f174. https://www.bmj.com/content/346/bmj.f174
— WHO. Effectiveness of sterile needle and syringe programming in reducing HIV/AIDS among injecting drug users, 2004. https://www.who.int/docs/default-source/substance-use/who-hiv-2004-03.pdf
— WHO. Guide to starting and managing needle and syringe programmes, 2007. https://www.who.int/publications/i/item/guide-to-starting-and-managing-needle-and-syringe-programmes
— WHO/UNODC/UNAIDS. Technical guide for countries to set targets for universal access to HIV prevention, treatment and care for injecting drug users, 2012. https://www.who.int/publications/i/item/978924150437

The material is informational in nature, is not medical consultation, and does not replace professional help.

↑ 6

Discussion

Comments

0

No comments yet.

Write Join to take part in the discussion.